Abstract
The aim of this study was to assess the possible association between the protein tyrosine phosphatase non-receptor 22 (PTPN22) gene 1858→T (rs2476601, encoding R620W) polymorphism and inflammatory bowel disease (IBD). Our study population consisted of 1113 IBD [544 ulcerative colitis (UC) and 569 Crohn's disease (CD)] patients and 812 healthy subjects. All the individuals were of Spanish white origin. Genotyping of the PTPN22 gene 1858C→T polymorphism was performed by real time polymerase chain reaction technology, using TaqMan 5′-allelic discrimination assay. The frequency of the PTPN22 1858T allele in healthy subjects was 6.2% compared with 6.7% in the UC patients and 5.1% in Crohn's patients. No statistically significant differences were observed when the PTPN22 1858C→T allele and genotype distribution among CD patients, UC patients and healthy controls were compared. These results indicate that the PTPN22 1858C→T polymorphism does not appear to play a major role in IBD predisposition in our population. © 2005 Blackwell Publishing Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | 314-317 |
| Number of pages | 3 |
| Journal | Tissue Antigens |
| Volume | 66 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Oct 2005 |
Keywords
- Crohn's disease
- Inflammatory bowel disease
- Lymphoid-specific phosphatase (LYP)
- PTPN22
- Ulcerative colitis
Fingerprint
Dive into the research topics of 'The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver